Randomized Phase III Trial of Haploidentical HCT with or without an Add back Strategy of HSV-Tk Donor Lymphocytes in Patients with High Risk Acute Leukemia

Type of Cancer
Lymphoma

Site
Hackensack

Sponsor
MolMed

Protocol Number
TK008

To Learn More Call
201-510-0910